SLU-PP-332 250mcg (60 Capsules)

Description

SLU-PP-332 is a potent synthetic REV-ERBα/β agonist, part of a class of nuclear receptor ligands being studied for their role in regulating circadian biology, metabolism, and mitochondrial activity. REV-ERB receptors are transcriptional repressors that influence a wide range of physiological processes, including energy homeostasis, lipid metabolism, and inflammatory signaling.

In preclinical models, SLU-PP-332 has demonstrated potential in reducing fat mass, improving glucose tolerance, and enhancing mitochondrial function—all without affecting food intake. These effects make it a promising tool for studying obesity, non-alcoholic fatty liver disease (NAFLD), insulin resistance, and sleep-wake cycle regulation.

How SLU-PP-332 Works (Based on Preclinical Research):

• Activates REV-ERBα/β to suppress genes involved in lipid storage and inflammation

• Enhances mitochondrial biogenesis and oxidative metabolism

• Modulates circadian rhythm pathways through transcriptional regulation

• Promotes fat oxidation and energy expenditure without stimulating appetite

Potential Benefits (Based on Preclinical Research):

• Support for fat loss and improved insulin sensitivity

• Regulation of circadian-related metabolic pathways

• Anti-inflammatory effects and liver health support

• Increased energy output and mitochondrial efficiency

⚠️ For Research Use Only. Not for Human Consumption.
This compound is not approved by the FDA or any regulatory body and is intended solely for laboratory research.